Chairman of Credorax Inc.
· CredoRax is a combined Merchant Acquiring Bank and a Technology Company.
· Credorax is licensed, in all 27 EU countries and is also a principal level member with Visa Europe and MasterCard worldwide.
OBV helped the company in its last round to raise funds from private investors.
Gil, Dan and Ariel Makov devoted a significant amount of time, energy and focused to help Credorax and introduce us to a variety of private and institutional investors.
Their methodical process and vast relationships enabled Credorax story to be presented to a significant number of leading investors.
Having worked with several bankers in the past, I wish to emphasize that OBV is one of the most professional teams out there.
Founder & CEO
Via Surgical Ltd.In our recent investment round we have had the pleasure of receiving services from OBV.
Via Surgical has raised a substantial amount from OBV and OBV contacts.
We were deeply impressed by their professional and rapid diligence process as well as their assistance in introductions and bringing in additional investors. Ariel Makov , OBV CEO, was very helpful and professional in getting deals done.
I would without hesitation recommend OBV to any young startup company who is looking to raise funds. Sincerely, Ofek
Irina Vaysbeyn, CEO, HDH Medical,
"HDH Medical is a medical device company that has developed an innovative vascular device and supporting surgical instruments, which enable suture-less open and laparoscopic vascular surgical procedures.
OBV team showed great capabilities in the field of contact initiation and follow up with potential partners and investors, which led to investment round closing.
Effective, fast and professional service of OBV team contributed to continuous success of our company."
Chief Executive Officer,
Endogun Medical Systems
"I was extremely impressed with the performance of OBV and the Makovs. They were able to bring significant investment leads within the framework of two financing rounds conducted by Endogun; and maintained close relationship with said investors and management of Endogun alike, until successful completion of the investments (the OBV leads accounted for 80% of Endogun’s last private financing round).
In doing so, OBV and the Makovs were not only extremely professional but also highly ethical, diligent and trustworthy. They proved themselves to be, over time, real partners of the Company, which bring tangible contribution to building its financial future."
Dr. Shlomi Ben-Ari, CEO
Orsan Medical Technologies Ltd.
"I was introduced to OBV a few months ago by a very distinguished investor .
This investor liked our company .Since he was planning only to take part of the investment, he preferred OBV to take care of the complementary investment using their screening and organizational abilities.
When OBV decided that they are interested in taking part with our investment round ,they where extremely efficient .
After a few days only, they have started to introduce us to their investors.
OBV´s reservoir of respectable investors is very big . More than that : they have very strong and warm relations with their investors.
Within short time we had learned to trust the OBV team.
They have learned carefully the company needs and priorities and after only a few months we have successfully closed our first part of investment .My current experience with OBV is a very positive one and I will continue to cooperate with them."
Dr. Eran Eilat
CEO, Peritech Pharma
Peritech Pharma develops innovative drugs for anal-rectal disorders. Its leading compound is in advanced clinical testing for treating hemorrhoids, and is set to revolutionize the field.
We approached OBV for help in fundraising our series A round, and received a very professional treatment. Within six months we ended up securing the required funding and OBV were supportive and instrumental throughout the process. I intend to use their services again
Uri Kariv, CEO
Safer Place Ltd.
I have had the pleasure of working with Orange Blossom Ventures during the course of our last investment rounds.
OBV’s process of matching investor to opportunity has been extremely efficient, with the round closing after three prospect meetings. Their involvement in the process is just as noteworthy with the rare capability of knowing where to let the process and meetings roll and where they should push forward
On the personal level it was a pleasure working with Ariel, and I would highly recommend them for any investment or BD match-making.
I highly appreciate the efficient, discreet and successful services rendered to me by OBV and by Dan and Ariel Makov in the sale transaction of a significant portion of Globrands to the Fishman group. I credit the Makov brothers for identifying a relevant quality buyer and for the efficiency of the negotiations.I am also appreciating their most significant contribution in bringing the deal to fruition.I'd be glad to use OBV & the Makovs in other transactions and to recommend them without reservation.
The team at OBV understood our company’s needs and worked closely with us, in order to found the best match and present us to our preferred investors.
OBV team has worked patiently and professionally and demonstrated excellent capabilities. Along with their methodical process and their network of professional contacts, they cooperated well to bring about an excellent deal.
I highly recommend startup companies who wish to be professionally presented to decision makers in the business, to consider engaging OBV’s services.
Dr. Gal Aviv,
Founder and CEO/ BLender